Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Estrella Immunopharma Inc...

    NASDAQ: ESLA · Real-Time Price · USD
    0.90
    -0.05 (-5.26%)
    At close: Jun 17, 2025, 3:55 PM
    0.93
    3.83%
    After-hours: Jun 17, 2025, 07:32 PM EDT

    Estrella Immunopharma Statistics

    Share Statistics

    Estrella Immunopharma has - shares outstanding. The number of shares has increased by -0.58% in one year.

    Shares Outstanding

    n/a
    		 n/a

    Shares Change (YoY)

    n/a
    		 -0.58%

    Shares Change (QoQ)

    n/a
    		 -0.04%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 10.1M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,069

    FTD / Avg. Volume

    n/a
    		 1.5%

    Short Selling Information

    The latest short interest is 11.54K, so 0.03% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 11.54K

    Short % of Shares Out

    n/a
    		 0.03%

    Short % of Float

    n/a
    		 0.11%

    Short Ratio (days to cover)

    n/a
    		 1.4

    Valuation Ratios

    The PE ratio is -5.3 and the forward PE ratio is -2.07. Estrella Immunopharma's PEG ratio is -0.23.

    PE Ratio

    n/a
    		 -5.3

    Forward PE

    n/a
    		 -2.07

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 9.06

    P/FCF Ratio

    n/a
    		 -2.41

    PEG Ratio

    n/a
    		 -0.23
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Estrella Immunopharma.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 24.65, with a Debt / Equity ratio of 0.

    Current Ratio

    n/a
    		 24.65

    Quick Ratio

    n/a
    		 24.65

    Debt / Equity

    n/a
    		 0

    Debt / EBITDA

    n/a
    		 n/a

    Debt / FCF

    n/a
    		 n/a

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 n/a

    Employee Count

    n/a
    		 undefined

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 1.63K

    Effective Tax Rate

    n/a
    		 -0.02%

    Stock Price Statistics

    The stock price has increased by 10.84% in the last 52 weeks. The beta is 0.37, so Estrella Immunopharma's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.37

    52-Week Price Change

    n/a
    		 10.84%

    50-Day Moving Average

    n/a
    		 0.98

    200-Day Moving Average

    n/a
    		 1.03

    Relative Strength Index (RSI)

    n/a
    		 42.43

    Average Volume (20 Days)

    n/a
    		 204,379

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -7.31M

    Net Income

    n/a
    		 -7.31M

    EBITDA

    n/a
    		 -7.31M

    EBIT

    n/a
    		 -7.31M

    Earnings Per Share (EPS)

    n/a
    		 -0.21
    Full Income Statement

    Balance Sheet

    The company has 4.17M in cash and 0 in debt, giving a net cash position of 4.17M.

    Cash & Cash Equivalents

    n/a
    		 4.17M

    Total Debt

    n/a
    		 n/a

    Net Cash

    n/a
    		 n/a

    Retained Earnings

    n/a
    		 -19.5M

    Total Assets

    n/a
    		 3.74M

    Working Capital

    n/a
    		 -753.71K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -16.07M and capital expenditures -4, giving a free cash flow of -16.07M.

    Operating Cash Flow

    n/a
    		 -16.07M

    Capital Expenditures

    n/a
    		 -4

    Free Cash Flow

    n/a
    		 -16.07M

    FCF Per Share

    n/a
    		 -0.46
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    ESLA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for ESLA is $16, which is 1677.8% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $16

    Price Target Difference

    n/a
    		 1677.8%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 1
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 -9.64

    Piotroski F-Score

    n/a
    		 0

    Add to Watchlist